Weekly epirubicin in the treatment of gestational breast cancer (GBC)

Breast Cancer Research and Treatment

Volumn 115, Issue 3, 2009, Pages 591-594

  Peccatori, Fedro A ^a   Azim Jr , Hatem A ^a   Scarfone, Giovanna ^b   Gadducci, Angiolo ^c   Bonazzi, Cristina ^d   Gentilini, Oreste ^a   Galimberti, Viviana ^a   Intra, Mattia ^a   Locatelli, Marzia ^a   Acaia, Barbara ^b   Rossi, Piero ^b   Cinieri, Saverio ^a,e   Calabrese, Liliana ^a   Goldhirsch, Aron ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF PISA   (Italy)

^d UNIVERSITY OF MILANO BICOCCA   (Italy)

^e PERRINO HOSPITAL   (Italy)

Author keywords

Breast cancer; Chemotherapy; Epirubicin; Foetus; Pregnancy; Safety

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ERYTHROPOIETIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; ALOPECIA; ANEMIA; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CESAREAN SECTION; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FETUS DISEASE; FOLLOW UP; GESTATIONAL AGE; GESTATIONAL BREAST CANCER; HIGH RISK PATIENT; HIGH RISK PREGNANCY; HUMAN; KIDNEY POLYCYSTIC DISEASE; LIVER METASTASIS; MATERNAL AGE; MATERNAL HYPERTENSION; METASTASIS; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; PREECLAMPSIA; PREMATURE LABOR; PRIORITY JOURNAL; STOMATITIS; UNSPECIFIED SIDE EFFECT;

ADULT; ANTIBIOTICS, ANTINEOPLASTIC; BREAST NEOPLASMS; EPIRUBICIN; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; PROGNOSIS; SURVIVAL RATE;

EID: 67349254130     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-0159-2     Document Type: Article

References (25)

1. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 74 108 (Pubitemid 40372904)
2. GS Berkowitz ML Skovron RH Lapinski RL Berkowitz 1990 Delayed childbearing and the outcome of pregnancy N Engl J Med 322 639 664
3. JF Haas 1989 Pregnancy is association with newly-diagnosed cancer: a population-based epidemiologic assessment Int J Cancer 34 229 235 10.1002/ijc.2910340214
4. S Loibl G von Minckwitz K Gwtn P Ellis JU Blohmer B Schlegelberger 2006 Breast carcinoma during pregnancy. International recommendations from an expert meeting Cancer 106 237 246 10.1002/cncr.21610
5. Boldrini R, Di Cesare M, Tamburini C (eds) (2007) Rapporto CeDAP, 2004. Italian Ministry of Health website ( www.ministerosalute.it )
6. AE Ring IE Smith A Jones C Shannon E Galani PA Ellis 2005 Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals J Clin Oncol 23 4192 4197 10.1200/JCO.2005.03.038
7. E Cardonick A Iacobucci 2004 Use of chemotherapy during human pregnancy Lancet Oncol 5 283 291 10.1016/S1470-2045(04)01466-4
8. R Cohen-Kerem C Railton D Oren M Lishner G Koren 2005 Pregnancy outcome following non-obstetric surgical intervention Am J Surg 190 467 473 10.1016/j.amjsurg.2005.03.033
9. R Orecchia G Lucignani G Tosi 2008 Prenatal irradiation and pregnancy: the effects of diagnostic imaging and radiation therapy Recent Results Cancer Res 178 3 20 10.1007/978-3-540-71274-9-2
10. DC Doll QS Ringenberg JW Yarbo 1989 Antineoplastic agents and pregnancy Semin Oncol 16 337 346 (Pubitemid 19259007)
11. D Zemlickis M Lishner P Degendorfer T Panzarella SB Sutcliffe G Koren 1992 Fetal outcome after in utero exposure to cancer chemotherapy Arch Intern Med 152 573 576 10.1001/archinte.152.3.573
12. L Barthelmes LA Davidson C Gaffney CA Gateley 2005 Pregnancy and breast cancer BMJ 330 1375 1378 10.1136/bmj.330.7504.1375 (Pubitemid 40839572)
13. G Bonadonna L Gianni A Santoro V Bonfante P Bidoli P Casali 1993 Drugs ten years later: epirubicin Ann Oncol 4 359 369 (Pubitemid 23193100)
14. CJ Twelves SM O'Reilly RE Coleman MA Richards RD Rubens 1989 Weekly epirubicin for breast cancer liver metastasis and abnormal liver biochemistry Br J Cancer 60 938 941 (Pubitemid 20024190)
15. A Goldhirsch WC Wood RD Gelber AS Coates B Thurlimann HJ Senn 2007 Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007 Ann Oncol 18 1133 1144 10.1093/annonc/mdm271
16. Myers C (1988) Role of iron in anthracycline action. In: Hacker M, Lazo J, Tritton T (eds) Organ directed toxicities of anticancer drugs. Martinus Nijhoff, Boston, Mass, pp 17-30
17. C Clapp S Thebault G Martinez de la Escalera 2007 Hormones and pospartum cardiomyopathy Trends Endocrinol Metab 18 329 330 10.1016/j.tem.2007.08.004
18. ET Yeh AT Tong DJ Lenihan SW Yusuf J Swafford C Champion 2004 Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management Circulation 109 3122 3131 10.1161/01.CIR.0000133187.74800.B9
19. KM Hahn PH Johnson N Gordon H Kuerer L Middleton M Ramirez 2006 Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero Cancer 107 1219 1226 10.1002/cncr.22081
20. CM Camaggi E Strocchi R Comparsi F Testoni B Angelelli F Pannuti 1986 Biliary excretion and pharmacokinetics of 4′epidoxorubicin (epirubicin) in advanced cancer patients Cancer Chemother Pharmacol 18 47 50 10.1007/BF00253063
21. J Kushari M Mukherjea 1980 Studies on beta-glucuronidase of the developing human placenta Gynecol Obstet Invest 11 119 127 (Pubitemid 10033660)
22. F Peccatori G Martinelli O Gentilini A Goldhirsch 2004 Chemotherapy during pregnancy: what is really safe? Lancet Oncol 5 398 10.1016/S1470-2045(04) 01506-2
23. AH Partridge JE Garber 2000 Long-term outcomes of children exposed to antineoplastic agents in utero Semin Oncol 27 712 726
24. K Gwyn 2005 Children exposed to chemotherapy in utero J Natl Cancer Inst Monogr 34 69 71 10.1093/jncimonographs/lgi009
25. A Aviles N Neri MJ Nambo 2006 Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy Ann Oncol 17 286 288 10.1093/annonc/mdj053